STRM
Streamline Health Solutions, Inc.
Set alert
- YTD
- +41.84%
- 1 year
- -24.35%
- Open
- 5.33
- Prev close
- 5.33
- Mkt cap
- 13.95M
- Vol
- 4.06K
- Avg vol
- 56.03K
- EPS
- -2.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.33
- High
- 5.33
- Forward P/E
- -29.73
- Beta
- 1.64
- Short ratio
- 0.62
- Inst. own
- 20.37%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.75
- 200-d avg
- 5.35
- 1y target
- 22.50
Key statistics
- Market cap
- 13.95M
- Enterprise value
- 124.45M
- Trailing P/E
- 0.00
- Forward P/E
- -29.73
- PEG ratio
- 0.00
- Price / sales
- 0.69
- Price / book
- 4.37
- EPS (TTM)
- -2.31
- Beta
- 1.64
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -92.72%
- Revenue (TTM)
- 20.30M
- Revenue growth
- -0.70%
- Free cash flow
- -1.61M
- Total cash
- 15.85M
- Total debt
- 330.00K
- Return on equity
- -80.09%
- Shares outstanding
- 4.22M
- Short % of float
- 0.65%
- 50-day average
- 2.75
- 200-day average
- 5.35
Analyst view
Consensus: none
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 16, 2024 | Oct 1, 2024 | 0.00 | -0.61 | — | — |
| Sep 11, 2024 | Jul 1, 2024 | 0.00 | -0.75 | — | — |
| Jun 11, 2024 | Apr 1, 2024 | 0.00 | -0.75 | — | — |
| Apr 29, 2024 | Jan 1, 2024 | 0.00 | -0.30 | — | — |
| Dec 13, 2023 | Oct 1, 2023 | 0.00 | -0.30 | — | — |
| Sep 13, 2023 | Jul 1, 2023 | 0.00 | -0.60 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 20, 2022 | Lake Street | init | — | Buy |
| Apr 25, 2016 | Lake Street | down | Buy | Hold |
| Sep 4, 2015 | Cowen & Co. | main | — | Outperform |
| Feb 4, 2014 | Lake Street | init | — | Buy |
| Dec 3, 2013 | Avondale Partners | init | — | Market Outperform |
About Streamline Health Solutions, Inc.
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in North America. The company offers RevID, a cloud-based automated revenue reconciliation software as a service (Saas) solution that delivers automated daily charge reconciliation, which identifies discrepancies between a provider's clinical and billing departments and ensures that every medical service is tracked, accounted for, and accurately billed and reduce revenue leakage; and eValuator, a coding analysis platform that delivers the capability of fully automated analysis on billing codes entered by a healthcare provider's coding team. It also provides Data Comparison Engine, a cloud-based SaaS system synchronization module that operates and automates the reconciliation of these systems to identify discrepancies or errors occurring between systems; CDI that provides an integrated on-premise or cloud-based software suite that enhances the productivity of CDI and Coding staff and enables the seamless sharing of patient data; and Financial Management Solutions, which offers financial staff across the healthcare enterprise with actionable and real-time financial data and key performance indicators to improve revenue realization. In addition, the company provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- streamlinehealth.net
News
- Storm Closes Oversubscribed $3.2M Private Placement
- Storm Exploration Inc. to Present at Deutsche Goldmesse Spring 2026 in Frankfurt
- Storm Exploration Issues Shares to Eabametoong First Nation
- STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
- Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
- Storm Exploration Appoints Dr. Alexander Shaw to Board of Directors
- Storm Exploration Appoints Cameron Dorsey to Its Advisory Board
- STREAMLINE HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Streamline Health Solutions, Inc. - STRM
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, ENZB, STRM on Behalf of Shareholders
- Storm Exploration Effects Share Consolidation
Your note
Sign in to keep a note on STRM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ETHERIDGE MATTHEW W | Director | Stock Award(Grant) | Feb 6, 2024 | 463,158 |
| FERAYORNI JUSTIN JOHN | Director | Stock Award(Grant) | Jul 17, 2024 | 5,764,520 |
| GIBSON THOMAS J | Chief Financial Officer | Stock Award(Grant) | Mar 30, 2023 | 617,585 |
| GREEN WYCHE T III | Director | Stock Award(Grant) | Jul 17, 2024 | 2,490,700 |
| LOVVORN WENDY L | Officer | Stock Award(Grant) | Apr 28, 2024 | 528,766 |
| LUCAS KENAN H. | Director | Stock Award(Grant) | Jul 17, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Perkins Capital Management, Inc. | 3.05% | 1,932,959 | 6.32M | Sep 29, 2024 |
| Nicholas Hoffman & Company, LLC. | 1.14% | 722,044 | 2.36M | Sep 29, 2024 |
| Harbert Fund Advisors, Inc. | 0.51% | 321,616 | 1.05M | Sep 29, 2024 |
| Vanguard Group Inc | 0.18% | 111,309 | 363.98K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.05% | 33,519 | 109.61K | Sep 29, 2024 |
| Salem Investment Counselors, Inc. | 0.03% | 18,184 | 59.46K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| World Funds Tr-Perkins Discovery Fund | 0.21% | 131,000 | 428.37K | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 0.11% | 68,503 | 224.00K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.07% | 42,067 | 137.56K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.03% | 19,155 | 62.64K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.01% | 6,305 | 20.62K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.01% | 4,658 | 15.23K | Oct 30, 2024 |